Blog

Premier Medical Group Celebrates Clinical Trial Success as FDA Approves Viekira Pak™

Premier Medical Group’s Clinical Research Division had a lot to celebrate this holiday season.   The FDA just approved Viekira Pak™ to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis. Premier Medical’s Clinical Research Division was responsible for eight Viekira Pak™ clinical […]

Read More

What is Rheumatic Disease and Rheumatology?

An estimated 46 million adults suffer from rheumatic diseases in the United States. These are complex autoimmune and inflammatory diseases that cause the immune system to attack and damage the joints, tendons, ligaments, bones, muscles and sometimes involve damage to internal organs. They cause pain, inflammation, life-changing disability and, in severe cases, can cause or […]

Read More

New Ways for Coping with Crohn’s Disease

Biologics have been effective for many patients, but not for all. New drugs, with new mechanisms of action, promise more help and hope. Crohn’s disease is an inflammatory bowel disease (IBD) affecting the lining of the digestive tract, often spreading deep into the lining of the affected organ. The cause of the disease remains a […]

Read More